Comparison of percutaneous radiofrequency thermal ablation and surgical resection for small hepatocellular carcinoma

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Nishikawa, Hiroki ^a   Inuzuka, Tadashi ^a   Takeda, Haruhiko ^a   Nakajima, Jun ^a   Matsuda, Fumihiro ^a   Sakamoto, Azusa ^a   Henmi, Shinichiro ^a   Hatamaru, Keiichi ^a   Ishikawa, Tetsuro ^a   Saito, Sumio ^a   Nasu, Akihiro ^a   Kita, Ryuichi ^a   Kimura, Toru ^a   Arimoto, Akira ^a   Osaki, Yukio ^a  

^a OSAKA RED CROSS HOSPITAL   (Japan)

Author keywords

Hcc; Prfa; Recurrence; Surgical resection; Survival

Indexed keywords

ALPHA FETOPROTEIN; BILIRUBIN; SERUM ALBUMIN;

ABDOMINAL BLEEDING; ADULT RESPIRATORY DISTRESS SYNDROME; ADVERSE OUTCOME; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; ASCITES; BILE LEAKAGE; BILIRUBIN BLOOD LEVEL; BILOMA; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL HEMORRHAGE; GENDER; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; PERCUTANEOUS RADIOFREQUENCY THERMAL ABLATION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN INDUCED VITAMIN K ABSENCE; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; RISK FACTOR; SURGICAL TECHNIQUE; SURVIVAL RATE; THROMBOCYTE COUNT; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR VOLUME; COMPARATIVE STUDY; DISEASE COURSE; FOLLOW UP; LIVER RESECTION; LIVER TUMOR; LOW LEVEL LASER THERAPY; METHODOLOGY; MIDDLE AGED; MORTALITY;

AGED; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LASER THERAPY; LENGTH OF STAY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84455173830     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-143     Document Type: Article

References (32)

1. Bosch X, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999, 19:271-85. 10.1055/s-2007-1007117, 10518307.
2. Liver Cancer Study Group of Japan Primary liver cancers in Japan. Cancer 1980, 45:2663-69. 10.1002/1097-0142(19800515)45:10<2663::AID-CNCR2820451030>3.0.CO;2-G, 6155197, Liver Cancer Study Group of Japan.
3. Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Hepatic resection for hepatocellular carcinoma: an audit of 343 patients. Ann Surg 1995, 221:291-98. 10.1097/00000658-199503000-00012, 1234572, 7717783.
4. Lau WY, Leung TW, Yu SC, Ho SK. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 2003, 237:171-79. 1522146, 12560774.
5. Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long term results. Eur Radiol 2001, 11:914-21. 10.1007/s003300000659, 11419162.
6. Nicoli N, Casari A, Marchiori L. Intraoperative and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular carcinoma. Chir Ital 2000, 52:29-40.
7. Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations and complications. Ann Surg Oncol 2000, 7:593-600.
8. Rossi S, Buscarini E, Garbagnati F, Di Stasi M, Quaretti P, Rago M, Zangrandi A, Andreola S, Silverman D, Buscarini L. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. Am J Roentgenol 1998, 170:1015-22.
9. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, Ishikawa T, Koike Y, Yoshida H, Kawabe T, Omata M. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005, 129:122-30. 10.1053/j.gastro.2005.04.009, 16012942.
10. Bruix J, Sherman M, . Practice Guidelines Committee, American Association for the Study of Liver Diseases Management of hepatocellular carcinoma. Hepatology 2005, (42):(5): 1208-1236. Practice Guidelines Committee, American Association for the Study of Liver Diseases.
11. Yamasaki T, Kurokawa F, Shirahashi H, Kusano N, Hironaka K, Okita K. Percutaneous radiofrequency ablation therapy with combined angiography and computed tomography assistance for patients with hepatocellular carcinoma. Cancer 2001, 91(7):1342-8. 10.1002/1097-0142(20010401)91:7<1342::AID-CNCR1137>3.0.CO;2-0, 11283935.
12. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Lin XJ, Lau WY. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006, 243:321-28. 10.1097/01.sla.0000201480.65519.b8, 1448947, 16495695.
13. Grazi GL, Ercolani G, Pierangeli F, Gaudio MD, Cescon M, Cavallari A, Mazziotti A. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 2001, 234:71-8. 10.1097/00000658-200107000-00011, 1421950, 11420485.
14. Rahbari NN, Mehrabi A, Mollberg NM, Müller SA, Koch M, Büchler MW, Weitz J. Hepatocellular carcinoma. Current management and perspectives for the future. Ann Surg 2011, 253:453-69. 10.1097/SLA.0b013e31820d944f, 21263310.
15. Lencioni RA, Allgaier HP, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum HE, Bartolozzi C. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 2003, 228:235-40. 10.1148/radiol.2281020718, 12759473.
16. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 2004, 127:1714-23. 10.1053/j.gastro.2004.09.003, 15578509.
17. Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005, 54:1151-56. 10.1136/gut.2004.045203, 1774888, 16009687.
18. Sala M, Llovet JM, Vilana R, Bianchi L, Solé M, Ayuso C, Brú C, Bruix J, . Barcelona Clínic Liver Cancer Group Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004, 40:1352-60. 10.1002/hep.20465, 15565564, Barcelona Clínic Liver Cancer Group.
19. Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy. Oncology 2007, 72:98-103. 10.1159/000111714, 18087189.
20. Guglielmi A, Ruzzenete A, Sandri M. Radiofrequency ablation for hepatocellular carcinoma in cirrhotic patients: prognostic factors for survival. J Gastrointest Surg 2007, 11:143-149. 10.1007/s11605-006-0082-y, 17390163.
21. Shi M, Zhang CQ, Zhang YQ, Liang XM, Li JQ. Micrometastasis of solitary heaptocellular carcinoma and appropriate resection margin. World J Surg 2004, 28:376-81. 10.1007/s00268-003-7308-x, 15022021.
22. Regimbeu JM, Kianmanesh R, Farges O, Dondero F, Sauvanet A, Belghiti JSO. Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 2002, 131:311-17. 10.1067/msy.2002.121892, 11894036.
23. Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, Sano K, Sugawara Y, Takayama T, Makuuchi M. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005, 242:252-59. 10.1097/01.sla.0000171307.37401.db, 1357731, 16041216.
24. Sasaki A, Kai S, Iwashita Y, Hirano S, Ohta M, Kitano S. Microsatellite distribution and indication for locoregional therapy in small hepatocellular carcinoma. Cancer 2005, 103:299-306. 10.1002/cncr.20798, 15578688.
25. Morimoto M, Numata K, Sugimori K, Shirato K, Kokawa A, Oka H, Hirasawa K, Koh R, Nihommatsu H, Tanaka K. Successful initial ablation therapy contributes to survival in patients with hepatocellular carcinoma. World J Gastroenterol 2007, 13:1003-09.
26. Lu MD, Kuang M, Liang LJ, Xie XY, Peng BG, Liu GJ, Li DM, Lai JM, Li SQ. Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial (in Chinese with English abstract). Zhonghua Yi Xue Za Zhi 2006, 86:801-05.
27. Montorsi M, Santambrogio R, Bianchi P, Donadon M, Moroni E, Spinelli A, Costa M. Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg 2005, 9:62-7. 10.1016/j.gassur.2004.10.003, 15623446.
28. Hong SN, Lee SY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Rhee JC, Choi D, Lim HK, Lee KW, Joh JW. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 2005, 39:247-52. 10.1097/01.mcg.0000152746.72149.31, 15718869.
29. Lupo L, Panzera P, Giannelli G, Memeo M, Gentile A, Memeo V. Single hepatocelluar carcinoma ranging from 3 to 5 cm: radiofrequency ablation or resection?. HPB (Oxford) 2007, 9:429-34.
30. Hasegawa K, Makuuchi M, Takayama T, Kokudo N, Arii S, Okazaki M, Okita K, Omata M, Kudo M, Kojiro M, Nakanuma Y, Takayasu K, Monden M, Matsuyama Y, Ikai I. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatology 2008, 49:589-594.
31. Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J, Xu Y, Zeng Y. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010, 252:903-12. 10.1097/SLA.0b013e3181efc656, 21107100.
32. Tateishi R, Shiina S, Teratani T Obi S, Sato S, Koike Y, Fujishima T, Yoshida H, Kawabe T, Omata M. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005, 103:1201-09. 10.1002/cncr.20892, 15690326.